Abstract
The purpose of this TriMark Publications report is to describe the specific
segment of the in vitro diagnostics (IVDs) market called women' s health
testing. This study includes contemporary and generally accepted clinical and
analytical activities. This analysis examines clinical measurement devices, as
well as their reagents and supplies, as utilized in hospitals, clinics and
doctor' s offices. Some diagnostic tests, which are marketed primarily as
over-the-counter products, are included in this report.
This report also includes other important tests like mammography, (i.e., tests
which are not generally associated with IVD tests, but which are an important
component of the overall women' s health market). This study deals with
analysis related to the common chemical constituents of blood, plasma or serum
of concern to patient testing in the field of women' s health. Emphasis is on
those companies and products that are actively developing and marketing
clinical laboratory instrumentation, reagents and supplies for performing
diagnostic tests related to women' s health. This study concentrates on the
women' s health testing market segment in important worldwide markets such as
the U.S., Japan and Europe.
|